SSH3 | slingshot protein phosphatase 3 | 11q13 | 0.351 | -0.573 | 0
|
FAM180A | family with sequence similarity 180, member A | 7q33 | 0.338 | 0.172 | 0.000374
|
PHF19 | PHD finger protein 19 | 9q34.11 | 0.336 | 0.503 | 0
|
RBP1 | retinol binding protein 1, cellular | 3q21-q23 | 0.335 | 0.201 | 2.92e-05
|
OXCT1 | 3-oxoacid CoA transferase 1 | 5p13 | 0.33 | 0.483 | 0
|
TMC4 | transmembrane channel-like 4 | 19q13.42 | 0.33 | -0.461 | 0
|
FBXO5 | F-box protein 5 | 6q25-q26 | 0.329 | 0.386 | 3.83e-18
|
MSH6 | mutS homolog 6 | 2p16 | 0.328 | 0.474 | 0
|
CPA3 | carboxypeptidase A3 (mast cell) | 3q24 | 0.327 | 0.075 | 0.122
|
TMEM38B | transmembrane protein 38B | 9q31.3 | 0.327 | 0.493 | 0
|
CNTLN | centlein, centrosomal protein | 9p22.2-p22.1 | 0.327 | 0.513 | 0
|
NADSYN1 | NAD synthetase 1 | 11q13.4 | 0.327 | -0.54 | 0
|
MCM6 | minichromosome maintenance complex component 6 | 2q14-q21 | 0.321 | 0.402 | 0
|
ANK2 | ankyrin 2, neuronal | 4q25-q26 | 0.321 | 0.41 | 0
|
CAPNS2 | calpain, small subunit 2 | 16q12.2 | 0.32 | -0.467 | 0
|
CDKN3 | cyclin-dependent kinase inhibitor 3 | 14q22 | 0.32 | 0.395 | 0
|
MSH2 | mutS homolog 2 | 2p21 | 0.318 | 0.298 | 3.89e-10
|
USP13 | ubiquitin specific peptidase 13 (isopeptidase T-3) | 3q26.2-q26.3 | 0.318 | 0.549 | 0
|
ZEB1 | zinc finger E-box binding homeobox 1 | 10p11.22 | 0.317 | 0.148 | 0.00212
|
BCAS1 | breast carcinoma amplified sequence 1 | 20q13.2 | 0.317 | -0.48 | 0
|
ANGPTL2 | angiopoietin-like 2 | 9q34 | 0.317 | 0.113 | 0.0197
|
COMT | catechol-O-methyltransferase | 22q11.21 | 0.316 | -0.501 | 0
|
REEP1 | receptor accessory protein 1 | 2p11.2 | 0.316 | 0.387 | 0
|
H2AFV | H2A histone family, member V | 7p13 | 0.316 | 0.449 | 0
|
DPF1 | D4, zinc and double PHD fingers family 1 | 19q13.12 | 0.315 | 0.406 | 0
|
SRSF12 | serine/arginine-rich splicing factor 12 | 6q16.1 | 0.315 | 0.48 | 0
|
ZNF385A | zinc finger protein 385A | 12q13.13 | 0.314 | -0.462 | 0
|
RUSC2 | RUN and SH3 domain containing 2 | 9p13.2 | 0.314 | 0.412 | 0
|
FANCC | Fanconi anemia, complementation group C | 9q22.3 | 0.314 | 0.438 | 0
|
SHOX2 | short stature homeobox 2 | 3q25.32 | 0.313 | 0.399 | 0
|
CYBRD1 | cytochrome b reductase 1 | 2q31 | 0.312 | 0.31 | 7.57e-11
|
PERM1 | PPARGC1 and ESRR induced regulator, muscle 1 | 1p36.33 | 0.312 | -0.514 | 0
|
STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 12q13 | 0.312 | -0.348 | 1.83e-13
|
SLFN11 | schlafen family member 11 | 17q12 | 0.311 | 0.449 | 0
|
TMC7 | transmembrane channel-like 7 | 16p13.11 | 0.31 | -0.542 | 0
|
GAS6 | growth arrest-specific 6 | 13q34 | 0.31 | 0.213 | 9.21e-06
|
TCF21 | transcription factor 21 | 6q23.2 | 0.31 | -0.085 | 0.0783
|
HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 16q24.1-q24.2 | 0.309 | -0.523 | 0
|
CTSG | cathepsin G | 14q12 | 0.309 | 0.062 | 0.202
|
SMOC2 | SPARC related modular calcium binding 2 | 6q27 | 0.308 | 0.08 | 0.0976
|
SYNM | synemin, intermediate filament protein | 15q26.3 | 0.308 | 0.255 | 1.08e-07
|
CMA1 | chymase 1, mast cell | 14q12 | 0.308 | 0.065 | 0.18
|
MCM2 | minichromosome maintenance complex component 2 | 3q21 | 0.308 | 0.377 | 5.69e-16
|
BTBD16 | BTB (POZ) domain containing 16 | 10q26.13 | 0.308 | -0.499 | 0
|
PNMAL1 | paraneoplastic Ma antigen family-like 1 | 19q13.32 | 0.307 | 0.223 | 3.49e-06
|
FSD1L | fibronectin type III and SPRY domain containing 1-like | 9q31 | 0.306 | 0.489 | 0
|
S100P | S100 calcium binding protein P | 4p16 | 0.306 | -0.546 | 0
|
PSIP1 | PC4 and SFRS1 interacting protein 1 | 9p22.2 | 0.305 | 0.518 | 0
|
PLCD3 | phospholipase C, delta 3 | 17q21 | 0.305 | -0.429 | 0
|
DENND2D | DENN/MADD domain containing 2D | 1p13.3 | 0.305 | -0.479 | 0
|
PDE10A | phosphodiesterase 10A | 6q26 | 0.305 | -0.429 | 0
|
HSPB6 | heat shock protein, alpha-crystallin-related, B6 | 19q13.13 | 0.304 | 0.127 | 0.00848
|
WDR62 | WD repeat domain 62 | 19q13.12 | 0.303 | 0.39 | 0
|
PKDCC | protein kinase domain containing, cytoplasmic | 2p21 | 0.303 | 0.328 | 5.13e-12
|
NT5M | 5',3'-nucleotidase, mitochondrial | 17p11.2 | 0.303 | 0.515 | 0
|
WDR17 | WD repeat domain 17 | 4q34 | 0.302 | 0.283 | 3.22e-09
|
RECK | reversion-inducing-cysteine-rich protein with kazal motifs | 9p13.3 | 0.302 | 0.365 | 8.78e-15
|
FAM111B | family with sequence similarity 111, member B | 11q12.1 | 0.302 | 0.32 | 1.63e-11
|
PRELID3A | PRELI domain containing 3A | 18p11.21 | 0.301 | 0.505 | 0
|
PLEKHN1 | pleckstrin homology domain containing, family N member 1 | 1p36.33 | 0.3 | -0.506 | 0
|
LMBR1L | limb development membrane protein 1-like | 12q13.12 | 0.298 | -0.432 | 0
|
ENTPD3 | ectonucleoside triphosphate diphosphohydrolase 3 | 3p21.3 | 0.298 | -0.418 | 0
|
S100A6 | S100 calcium binding protein A6 | 1q21 | 0.298 | -0.456 | 0
|
NPAS2 | neuronal PAS domain protein 2 | 2q11.2 | 0.298 | -0.484 | 0
|
MTHFD2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase | 2p13.1 | 0.298 | 0.451 | 0
|
SERINC2 | serine incorporator 2 | 1p35.1 | 0.298 | -0.54 | 0
|
UNC93B1 | unc-93 homolog B1 (C. elegans) | 11q13.2 | 0.297 | -0.439 | 0
|
ZNF385B | zinc finger protein 385B | 2q31.3-q32.1 | 0.297 | 0.425 | 0
|
SLC44A3 | solute carrier family 44, member 3 | 1p22.1 | 0.297 | -0.534 | 0
|
SVEP1 | sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 | 9q31-q32 | 0.297 | 0.157 | 0.00113
|
HECTD2-AS1 | HECTD2 antisense RNA 1 | 10q23.32 | 0.297 | -0.524 | 0
|
CCL14 | chemokine (C-C motif) ligand 14 | 17q12 | 0.296 | 0.051 | 0.293
|
ACOT11 | acyl-CoA thioesterase 11 | 1p32.3 | 0.296 | -0.482 | 0
|
ABCA10 | ATP-binding cassette, sub-family A (ABC1), member 10 | 17q24 | 0.296 | -0.473 | 0
|
GJC1 | gap junction protein, gamma 1, 45kDa | 17q21.31 | 0.295 | 0.461 | 0
|
AGTPBP1 | ATP/GTP binding protein 1 | 9q21.33 | 0.295 | 0.452 | 0
|
UGT1A6 | UDP glucuronosyltransferase 1 family, polypeptide A6 | 2q37 | 0.295 | -0.493 | 0
|
KCNJ15 | potassium channel, inwardly rectifying subfamily J, member 15 | 21q22.2 | 0.294 | -0.43 | 0
|
ARHGAP23 | Rho GTPase activating protein 23 | 17q12 | 0.293 | -0.42 | 0
|
APLP1 | amyloid beta (A4) precursor-like protein 1 | 19q | 0.293 | 0.451 | 0
|
NUF2 | NUF2, NDC80 kinetochore complex component | 1q23.3 | 0.292 | 0.269 | 1.84e-08
|
ELOVL4 | ELOVL fatty acid elongase 4 | 6q14 | 0.292 | 0.446 | 0
|
TMEM51 | transmembrane protein 51 | 1p36.21 | 0.292 | -0.468 | 0
|
NSUN6 | NOP2/Sun domain family, member 6 | 10p13 | 0.292 | -0.476 | 0
|
ITPRIPL1 | inositol 1,4,5-trisphosphate receptor interacting protein-like 1 | 2q11.2 | 0.291 | 0.377 | 5.65e-16
|
APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 11p15 | 0.291 | 0.481 | 0
|
CAND2 | cullin-associated and neddylation-dissociated 2 (putative) | 3p25.2 | 0.291 | 0.516 | 0
|
SRC | SRC proto-oncogene, non-receptor tyrosine kinase | 20q12-q13 | 0.291 | -0.515 | 0
|
NUDT11 | nudix (nucleoside diphosphate linked moiety X)-type motif 11 | Xp11.22-p11.1 | 0.291 | 0.256 | 8.6e-08
|
ATF7IP2 | activating transcription factor 7 interacting protein 2 | 16p13.2 | 0.29 | -0.434 | 0
|
AKAP5 | A kinase (PRKA) anchor protein 5 | 14q23.3 | 0.289 | 0.419 | 0
|
DIRAS1 | DIRAS family, GTP-binding RAS-like 1 | 19p13.3 | 0.289 | 0.325 | 7.17e-12
|
SH3BP1 | SH3-domain binding protein 1 | 22q13.1 | 0.289 | -0.52 | 0
|
FBXO10 | F-box protein 10 | 9p13.1 | 0.288 | 0.484 | 0
|
PABPC4L | poly(A) binding protein, cytoplasmic 4-like | 4q28.3 | 0.288 | 0.356 | 4.42e-14
|
NRXN1 | neurexin 1 | 2p16.3 | 0.288 | 0.216 | 7.26e-06
|
TPSAB1 | tryptase alpha/beta 1 | 16p13.3 | 0.288 | 0.045 | 0.355
|
SLC14A1 | solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | 18q11-q12 | 0.288 | -0.441 | 0
|
GIPC1 | GIPC PDZ domain containing family, member 1 | 19p13.1 | 0.287 | -0.423 | 0
|
IFT122 | intraflagellar transport 122 | 3q21 | 0.286 | 0.444 | 0
|
FGD1 | FYVE, RhoGEF and PH domain containing 1 | Xp11.21 | 0.285 | 0.441 | 0
|
TCP11L1 | t-complex 11, testis-specific-like 1 | 11p13 | 0.285 | 0.426 | 0
|
PARP2 | poly (ADP-ribose) polymerase 2 | 14q11.2 | 0.284 | 0.338 | 1.05e-12
|
GPR37 | G protein-coupled receptor 37 (endothelin receptor type B-like) | 7q31 | 0.284 | 0.489 | 0
|
TNFRSF21 | tumor necrosis factor receptor superfamily, member 21 | 6p21.1 | 0.283 | -0.497 | 0
|
ORAI3 | ORAI calcium release-activated calcium modulator 3 | 16p11.2 | 0.283 | -0.332 | 2.66e-12
|
KIAA1522 | KIAA1522 | 1p35.1 | 0.283 | -0.37 | 2.73e-15
|
TSPAN14 | tetraspanin 14 | 10q23.1 | 0.281 | -0.453 | 0
|
ARRB2 | arrestin, beta 2 | 17p13 | 0.281 | 0.393 | 0
|
COCH | cochlin | 14q11.2-q13 | 0.281 | 0.406 | 0
|
STXBP1 | syntaxin binding protein 1 | 9q34.1 | 0.28 | 0.506 | 0
|
CTSE | cathepsin E | 1q32.1 | 0.28 | -0.45 | 0
|
RADIL | Ras association and DIL domains | 7p22.1 | 0.279 | 0.392 | 0
|
PCDH9 | protocadherin 9 | 13q21.32 | 0.279 | 0.41 | 0
|
EFR3B | EFR3 homolog B | 2p24.1 | 0.278 | 0.275 | 9.19e-09
|
ADD2 | adducin 2 (beta) | 2p13.3 | 0.277 | 0.443 | 0
|
TRIM8 | tripartite motif containing 8 | 10q24.3 | 0.277 | -0.411 | 0
|
FLOT2 | flotillin 2 | 17q11.2 | 0.277 | -0.425 | 0
|
KDELC2 | KDEL (Lys-Asp-Glu-Leu) containing 2 | 11q32 | 0.277 | 0.415 | 0
|
SNX10 | sorting nexin 10 | 7p15.2 | 0.277 | 0.292 | 8.88e-10
|
S100A11 | S100 calcium binding protein A11 | 1q21 | 0.276 | -0.37 | 2.84e-15
|
IGFBPL1 | insulin-like growth factor binding protein-like 1 | 9p12 | 0.276 | 0.377 | 5.17e-16
|
PLEKHA4 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 | 19q13.33 | 0.276 | 0.262 | 4.3e-08
|
LTBR | lymphotoxin beta receptor (TNFR superfamily, member 3) | 12p13 | 0.276 | -0.335 | 1.5e-12
|
RGN | regucalcin | Xp11.3 | 0.275 | 0.053 | 0.276
|
SGSM3 | small G protein signaling modulator 3 | 22q13.1-q13.2 | 0.274 | -0.399 | 0
|
TAF4B | TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa | 18q11.1 | 0.274 | 0.427 | 0
|
CNIH2 | cornichon family AMPA receptor auxiliary protein 2 | 11q13.2 | 0.273 | 0.253 | 1.23e-07
|
HAS3 | hyaluronan synthase 3 | 16q22.1 | 0.273 | -0.456 | 0
|
ANXA10 | annexin A10 | 4q32.3 | 0.272 | -0.455 | 0
|
LPCAT4 | lysophosphatidylcholine acyltransferase 4 | 15q14 | 0.272 | -0.458 | 0
|
UGT1A9 | UDP glucuronosyltransferase 1 family, polypeptide A9 | 2q37 | 0.272 | -0.511 | 0
|
FAM184A | family with sequence similarity 184, member A | 6q22.31 | 0.271 | 0.468 | 0
|
ADGRB3 | adhesion G protein-coupled receptor B3 | 6q12 | 0.271 | 0.081 | 0.0942
|
DBF4 | DBF4 zinc finger | 7q21.3 | 0.271 | 0.316 | 2.85e-11
|
ARMC4 | armadillo repeat containing 4 | 10p12.1 | 0.271 | 0.379 | 3.73e-16
|
MAP7D3 | MAP7 domain containing 3 | Xq26.3 | 0.271 | 0.493 | 0
|
ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 12q23.1 | 0.27 | 0.376 | 7.48e-16
|
CYP46A1 | cytochrome P450, family 46, subfamily A, polypeptide 1 | 14q32.2 | 0.27 | 0.384 | 3.8e-17
|
SLC36A4 | solute carrier family 36 (proton/amino acid symporter), member 4 | 11q21 | 0.27 | 0.384 | 4.65e-17
|
TMBIM1 | transmembrane BAX inhibitor motif containing 1 | 2q35 | 0.269 | -0.426 | 0
|
HS3ST1 | heparan sulfate (glucosamine) 3-O-sulfotransferase 1 | 4p16 | 0.269 | -0.441 | 0
|
CAPN1 | calpain 1, (mu/I) large subunit | 11q13 | 0.269 | -0.473 | 0
|
GPR156 | G protein-coupled receptor 156 | 3q13.33 | 0.269 | 0.522 | 0
|
PXN | paxillin | 12q24 | 0.269 | -0.305 | 1.53e-10
|
TXNDC16 | thioredoxin domain containing 16 | 14q22.1 | 0.268 | 0.326 | 6.57e-12
|
GALNT16 | polypeptide N-acetylgalactosaminyltransferase 16 | 14q24.1 | 0.268 | 0.405 | 0
|
RHBDL3 | rhomboid, veinlet-like 3 (Drosophila) | 17q11.2 | 0.267 | 0.356 | 4.07e-14
|
KCNG3 | potassium channel, voltage gated modifier subfamily G, member 3 | 2p21 | 0.266 | 0.48 | 0
|
ANKRD65 | ankyrin repeat domain 65 | 1p36.33 | 0.266 | -0.476 | 0
|
CORO1B | coronin, actin binding protein, 1B | 11q13.1 | 0.266 | -0.503 | 0
|
PPP1R13L | protein phosphatase 1, regulatory subunit 13 like | 19q13.32 | 0.266 | -0.369 | 3.37e-15
|
CARD11 | caspase recruitment domain family, member 11 | 7p22 | 0.266 | -0.481 | 0
|
GALE | UDP-galactose-4-epimerase | 1p36-p35 | 0.265 | -0.439 | 0
|
RFK | riboflavin kinase | 9q21.31 | 0.265 | 0.413 | 0
|
HOOK1 | hook microtubule-tethering protein 1 | 1p32.1 | 0.264 | 0.05 | 0.3
|
DPY19L2P2 | DPY19L2 pseudogene 2 | 7q22.1 | 0.264 | 0.49 | 0
|
SLC37A2 | solute carrier family 37 (glucose-6-phosphate transporter), member 2 | 11q24.2 | 0.264 | -0.399 | 0
|
UBA7 | ubiquitin-like modifier activating enzyme 7 | 3p21 | 0.264 | -0.271 | 1.52e-08
|
TUB | tubby bipartite transcription factor | 11p15.5 | 0.264 | 0.473 | 0
|
EOGT | EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase | 3p14.1 | 0.263 | -0.245 | 3.13e-07
|
TINAGL1 | tubulointerstitial nephritis antigen-like 1 | 1p34.3 | 0.263 | -0.466 | 0
|
STK33 | serine/threonine kinase 33 | 11p15.3 | 0.262 | 0.367 | 5.21e-15
|
LPAR2 | lysophosphatidic acid receptor 2 | 19p12 | 0.262 | -0.43 | 0
|
TMEM102 | transmembrane protein 102 | 17p13.1 | 0.261 | -0.469 | 0
|
NUP210 | nucleoporin 210kDa | 3p25 | 0.261 | 0.283 | 3.06e-09
|
PIK3IP1 | phosphoinositide-3-kinase interacting protein 1 | 22q12.2 | 0.261 | -0.366 | 6.23e-15
|
AHR | aryl hydrocarbon receptor | 7p15 | 0.261 | -0.35 | 1.38e-13
|
IGF2 | insulin-like growth factor 2 | 11p15.5 | 0.26 | -0.259 | 6.03e-08
|
SLC25A51 | solute carrier family 25, member 51 | 9p13.3-p12 | 0.26 | 0.4 | 0
|
FAM219A | family with sequence similarity 219, member A | 9p11.2 | 0.26 | 0.385 | 1.41e-17
|
ZBTB7A | zinc finger and BTB domain containing 7A | 19p13.3 | 0.259 | -0.381 | 1.58e-16
|
STXBP5L | syntaxin binding protein 5-like | 3q13.33-q21.1 | 0.259 | 0.243 | 4.1e-07
|
PCOLCE2 | procollagen C-endopeptidase enhancer 2 | 3q21-q24 | 0.259 | 0.424 | 0
|
PTPRU | protein tyrosine phosphatase, receptor type, U | 1p35.3 | 0.259 | -0.411 | 0
|
GNAZ | guanine nucleotide binding protein (G protein), alpha z polypeptide | 22q11.1-q11.2 | 0.258 | 0.401 | 0
|
KIAA0895 | KIAA0895 | 7p14.2 | 0.258 | 0.401 | 0
|
ESYT3 | extended synaptotagmin-like protein 3 | 3q22.3 | 0.258 | 0.48 | 0
|
ASIC1 | acid sensing (proton gated) ion channel 1 | 12q12 | 0.258 | 0.443 | 0
|
SHANK2 | SH3 and multiple ankyrin repeat domains 2 | 11q13.2 | 0.258 | -0.291 | 9.95e-10
|
TSPO | translocator protein (18kDa) | 22q13.3 | 0.257 | -0.489 | 0
|
GPR137C | G protein-coupled receptor 137C | 14q22.1 | 0.257 | 0.27 | 1.68e-08
|
AGBL5 | ATP/GTP binding protein-like 5 | 2p23.3 | 0.257 | 0.155 | 0.00132
|
SOX13 | SRY (sex determining region Y)-box 13 | 1q32 | 0.257 | -0.4 | 0
|
PRDM5 | PR domain containing 5 | 4q25-q26 | 0.257 | 0.364 | 9.91e-15
|
ENKUR | enkurin, TRPC channel interacting protein | 10p12.31 | 0.256 | 0.266 | 2.58e-08
|
RNF157 | ring finger protein 157 | 17q25.3 | 0.256 | 0.279 | 5.51e-09
|
MCOLN3 | mucolipin 3 | 1p22.3 | 0.256 | 0.433 | 0
|
TRADD | TNFRSF1A-associated via death domain | 16q22 | 0.256 | -0.366 | 6.54e-15
|
SCD5 | stearoyl-CoA desaturase 5 | 4q21.3 | 0.256 | 0.394 | 0
|
POLD4 | polymerase (DNA-directed), delta 4, accessory subunit | 11q13 | 0.256 | -0.299 | 3.72e-10
|
PYGO1 | pygopus family PHD finger 1 | 15q21.1 | 0.255 | 0.475 | 0
|
ANKRD53 | ankyrin repeat domain 53 | 2p13.3 | 0.255 | 0.243 | 3.98e-07
|
SLC2A9 | solute carrier family 2 (facilitated glucose transporter), member 9 | 4p16.1 | 0.255 | -0.314 | 3.93e-11
|
LHX2 | LIM homeobox 2 | 9q33.3 | 0.255 | 0.406 | 0
|
DPYSL5 | dihydropyrimidinase-like 5 | 2p23.3 | 0.255 | 0.331 | 3.06e-12
|
KCNN4 | potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 | 19q13.2 | 0.254 | -0.478 | 0
|
OCIAD2 | OCIA domain containing 2 | 4p12 | 0.254 | -0.418 | 0
|
TRABD | TraB domain containing | 22q13.33 | 0.254 | -0.432 | 0
|
SYNGR3 | synaptogyrin 3 | 16p13.3 | 0.253 | 0.31 | 7.21e-11
|
FRMPD1 | FERM and PDZ domain containing 1 | 9p13.1 | 0.253 | 0.44 | 0
|
IGF2BP3 | insulin-like growth factor 2 mRNA binding protein 3 | 7p15.3 | 0.252 | 0.293 | 8.39e-10
|
WIPF3 | WAS/WASL interacting protein family, member 3 | 7p15.1 | 0.252 | 0.403 | 0
|
SLC30A3 | solute carrier family 30 (zinc transporter), member 3 | 2p23.3 | 0.252 | 0.455 | 0
|
ABCC10 | ATP-binding cassette, sub-family C (CFTR/MRP), member 10 | 6p12.3 | 0.252 | -0.334 | 1.95e-12
|
RRAGD | Ras-related GTP binding D | 6q15 | 0.251 | 0.421 | 0
|
TMEM136 | transmembrane protein 136 | 11q23.3 | 0.251 | 0.373 | 1.56e-15
|
ZC3H12A | zinc finger CCCH-type containing 12A | 1p34.3 | 0.25 | -0.262 | 4.17e-08
|
GFRA3 | GDNF family receptor alpha 3 | 5q31.1-q31.3 | 0.25 | 0.28 | 4.48e-09
|
AIG1 | androgen-induced 1 | 6q24.1 | 0.249 | -0.449 | 0
|
GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | 19p13.3 | 0.249 | -0.354 | 6.26e-14
|
EPHA6 | EPH receptor A6 | 3q12.1 | 0.249 | 0.305 | 1.55e-10
|
SNX33 | sorting nexin 33 | 15q23 | 0.248 | -0.311 | 6.62e-11
|
SLC4A11 | solute carrier family 4, sodium borate transporter, member 11 | 20p13 | 0.248 | -0.393 | 0
|
RAPGEF3 | Rap guanine nucleotide exchange factor (GEF) 3 | 12q13.1 | 0.248 | -0.257 | 7.81e-08
|
ETV6 | ets variant 6 | 12p13 | 0.248 | -0.327 | 6e-12
|
VPS35 | VPS35 retromer complex component | 16q12 | 0.248 | -0.38 | 2.37e-16
|
RIMKLB | ribosomal modification protein rimK-like family member B | 12p13.31 | 0.248 | 0.44 | 0
|
IL4R | interleukin 4 receptor | 16p12.1-p11.2 | 0.247 | -0.153 | 0.00153
|
PCDH1 | protocadherin 1 | 5q31.3 | 0.246 | -0.409 | 0
|
SCN8A | sodium channel, voltage gated, type VIII alpha subunit | 12q13.1 | 0.246 | 0.319 | 1.79e-11
|
SLC20A1 | solute carrier family 20 (phosphate transporter), member 1 | 2q13 | 0.246 | -0.357 | 3.45e-14
|
CAPN12 | calpain 12 | 19q13.2 | 0.246 | -0.285 | 2.49e-09
|
VKORC1L1 | vitamin K epoxide reductase complex, subunit 1-like 1 | 7q11.21 | 0.246 | 0.334 | 1.96e-12
|
INPP4B | inositol polyphosphate-4-phosphatase type II B | 4q31.1 | 0.246 | -0.383 | 7.99e-17
|
PRSS22 | protease, serine, 22 | 16p13.3 | 0.245 | -0.292 | 8.73e-10
|
LINC01547 | long intergenic non-protein coding RNA 1547 | 21q22.3 | 0.245 | 0.414 | 0
|
LRRC75A | leucine rich repeat containing 75A | 17p11.2 | 0.245 | 0.29 | 1.14e-09
|
MLF1 | myeloid leukemia factor 1 | 3q25 | 0.244 | 0.323 | 1.07e-11
|
ATP11A | ATPase, class VI, type 11A | 13q34 | 0.244 | 0.247 | 2.65e-07
|
NANP | N-acetylneuraminic acid phosphatase | 20p11.1 | 0.244 | 0.282 | 3.6e-09
|
LYPLA2 | lysophospholipase II | 1p36.11 | 0.244 | -0.463 | 0
|
KLF11 | Kruppel-like factor 11 | 2p25 | 0.244 | 0.444 | 0
|
PCED1B | PC-esterase domain containing 1B | 12q13.11 | 0.243 | -0.335 | 1.65e-12
|
MYOF | myoferlin | 10q24 | 0.243 | -0.225 | 2.82e-06
|
IQCC | IQ motif containing C | 1p36.11-p34.2 | 0.243 | 0.127 | 0.00863
|
AGRN | agrin | 1p36.33 | 0.242 | -0.373 | 1.4e-15
|
CDKL2 | cyclin-dependent kinase-like 2 (CDC2-related kinase) | 4q21.21 | 0.242 | 0.376 | 6.89e-16
|
ARHGAP33 | Rho GTPase activating protein 33 | 19q13.13 | 0.242 | 0.249 | 2.02e-07
|
STAG3L4 | stromal antigen 3-like 4 (pseudogene) | 7q11.21 | 0.242 | 0.233 | 1.25e-06
|
APOBR | apolipoprotein B receptor | 16p11.2 | 0.242 | -0.284 | 2.69e-09
|
ST3GAL1 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | 8q24.22 | 0.242 | -0.359 | 2.39e-14
|
COBL | cordon-bleu WH2 repeat protein | 7p12.2-p12.1 | 0.242 | 0.324 | 8.78e-12
|
LINC00669 | MIR924 host gene | 18q12.2-q12.3 | 0.241 | 0.22 | 4.51e-06
|
PIP5K1A | phosphatidylinositol-4-phosphate 5-kinase, type I, alpha | 1q21.3 | 0.241 | 0.26 | 5.89e-08
|
USP51 | ubiquitin specific peptidase 51 | Xp11 | 0.241 | 0.388 | 0
|
KLHL15 | kelch-like family member 15 | Xp22.1-p21 | 0.24 | 0.394 | 0
|
C1orf115 | chromosome 1 open reading frame 115 | 1q41 | 0.24 | 0.301 | 2.68e-10
|
HRASLS | HRAS-like suppressor | 3q29 | 0.24 | 0.326 | 6.49e-12
|
TMEM220 | transmembrane protein 220 | 17p13.1 | 0.24 | 0.118 | 0.0152
|
APOL2 | apolipoprotein L, 2 | 22q12.3 | 0.239 | -0.246 | 3.03e-07
|
NEURL1B | neuralized E3 ubiquitin protein ligase 1B | 5q35.1 | 0.239 | 0.428 | 0
|
CNKSR2 | connector enhancer of kinase suppressor of Ras 2 | Xp22.12 | 0.239 | 0.28 | 4.68e-09
|
PLB1 | phospholipase B1 | 2p23.3 | 0.238 | -0.314 | 4.31e-11
|
MPP2 | membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) | 17q12-q21 | 0.238 | 0.395 | 0
|
MDFI | MyoD family inhibitor | 6p21 | 0.237 | -0.257 | 7.66e-08
|
NUCKS1 | nuclear casein kinase and cyclin-dependent kinase substrate 1 | 1q32.1 | 0.237 | 0.235 | 1.02e-06
|
KCNK6 | potassium channel, two pore domain subfamily K, member 6 | 19q13.1 | 0.237 | -0.023 | 0.641
|
HLTF | helicase-like transcription factor | 3q25.1-q26.1 | 0.236 | 0.225 | 2.89e-06
|
KCNH3 | potassium channel, voltage gated eag related subfamily H, member 3 | 12q13 | 0.235 | 0.357 | 3.69e-14
|
PPM1E | protein phosphatase, Mg2+/Mn2+ dependent, 1E | 17q24.2 | 0.235 | 0.258 | 7.49e-08
|
ANAPC4 | anaphase promoting complex subunit 4 | 4p15.31 | 0.235 | -0.291 | 1.06e-09
|
ARL13B | ADP-ribosylation factor-like 13B | 3q11 | 0.235 | 0.374 | 1.14e-15
|
SYT13 | synaptotagmin XIII | 11p11.2 | 0.235 | 0.212 | 1e-05
|
CLGN | calmegin | 4q28.3-q31.1 | 0.235 | 0.374 | 1.12e-15
|
CGREF1 | cell growth regulator with EF-hand domain 1 | 2p23.3 | 0.234 | 0.288 | 1.58e-09
|
PLEKHG4B | pleckstrin homology domain containing, family G (with RhoGef domain) member 4B | 5p15.33 | 0.234 | 0.265 | 3.2e-08
|
ZNF319 | zinc finger protein 319 | 16q21 | 0.234 | -0.385 | 2.84e-17
|
AK7 | adenylate kinase 7 | 14q32.31 | 0.234 | 0.403 | 0
|
CNNM1 | cyclin and CBS domain divalent metal cation transport mediator 1 | 10q24.2 | 0.233 | 0.186 | 0.000116
|
AMIGO2 | adhesion molecule with Ig-like domain 2 | 12q13.11 | 0.233 | -0.363 | 1.31e-14
|
CAST | calpastatin | 5q15 | 0.233 | -0.233 | 1.17e-06
|
HPCAL4 | hippocalcin like 4 | 1p34.2 | 0.232 | 0.367 | 5.02e-15
|
YBX2 | Y box binding protein 2 | 17p13.1 | 0.232 | 0.382 | 1.2e-16
|
ATP6V1G2 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | 6p21.3 | 0.232 | 0.193 | 6.34e-05
|
SIRT4 | sirtuin 4 | 12q24.31 | 0.231 | 0.307 | 1.16e-10
|
ZFP36L2 | ZFP36 ring finger protein-like 2 | 2p22.3-p21 | 0.231 | -0.165 | 0.000637
|
ABCC6P2 | ATP-binding cassette, sub-family C, member 6 pseudogene 2 | 16p13.11 | 0.23 | 0.36 | 2.01e-14
|
LYPLA2P1 | lysophospholipase II pseudogene 1 | 6p21.32 | 0.229 | -0.439 | 0
|
HECTD2 | HECT domain containing E3 ubiquitin protein ligase 2 | 10q23.32 | 0.229 | 0.376 | 8.04e-16
|
LGALS8 | lectin, galactoside-binding, soluble, 8 | 1q43 | 0.229 | -0.262 | 4.56e-08
|
HOMER3 | homer scaffolding protein 3 | 19p13.1 | 0.229 | -0.235 | 9.45e-07
|
FXR2 | fragile X mental retardation, autosomal homolog 2 | 17p13.3 | 0.229 | 0.192 | 6.58e-05
|
PRKAA2 | protein kinase, AMP-activated, alpha 2 catalytic subunit | 1p31 | 0.228 | 0.352 | 9.29e-14
|
RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 20p13 | 0.228 | -0.158 | 0.00105
|
PBX3 | pre-B-cell leukemia homeobox 3 | 9q33.3 | 0.228 | 0.378 | 4.03e-16
|
EFNA2 | ephrin-A2 | 19p13 | 0.227 | 0.078 | 0.108
|
GPR87 | G protein-coupled receptor 87 | 3q24 | 0.227 | -0.153 | 0.00157
|
YY1AP1 | YY1 associated protein 1 | 1q22 | 0.227 | 0.265 | 3.22e-08
|
BID | BH3 interacting domain death agonist | 22q11.2 | 0.226 | -0.365 | 7.78e-15
|
FHL2 | four and a half LIM domains 2 | 2q12.2 | 0.225 | -0.229 | 1.88e-06
|
SMG5 | SMG5 nonsense mediated mRNA decay factor | 1q21 | 0.225 | 0.156 | 0.00127
|
ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 17q21.32 | 0.224 | 0.346 | 2.44e-13
|
NCKIPSD | NCK interacting protein with SH3 domain | 3p21 | 0.223 | 0.116 | 0.0167
|
PDLIM1 | PDZ and LIM domain 1 | 10q23.1 | 0.222 | -0.31 | 7.06e-11
|
ART5 | ADP-ribosyltransferase 5 | 11p15.4 | 0.222 | 0.234 | 1.13e-06
|
LINC00526 | long intergenic non-protein coding RNA 526 | 18p11.31 | 0.222 | 0.238 | 7.23e-07
|
BOK | BCL2-related ovarian killer | 2q37.3 | 0.222 | -0.147 | 0.00231
|
IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 1q32.1 | 0.221 | -0.256 | 9.15e-08
|
FAM25A | family with sequence similarity 25, member A | 10q23.2 | 0.22 | -0.239 | 6.49e-07
|
DTX2 | deltex 2, E3 ubiquitin ligase | 7q11.23 | 0.219 | -0.248 | 2.42e-07
|
ARPC2 | actin related protein 2/3 complex, subunit 2, 34kDa | 2q36.1 | 0.217 | -0.337 | 1.2e-12
|
CABLES2 | Cdk5 and Abl enzyme substrate 2 | 20q13.33 | 0.215 | 0.14 | 0.00386
|
ENHO | energy homeostasis associated | 9p13.3 | 0.215 | 0.309 | 9.03e-11
|
APOBEC3H | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H | 22q13.1 | 0.215 | -0.217 | 6.45e-06
|
CDIPT | CDP-diacylglycerol--inositol 3-phosphatidyltransferase | 16p11.2 | 0.214 | -0.223 | 3.6e-06
|
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | 16p13.11 | 0.213 | 0.316 | 3.11e-11
|
HOXB13 | homeobox B13 | 17q21.32 | 0.213 | 0.315 | 3.4e-11
|
DDX19B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 19B | 16q22.3 | 0.212 | -0.367 | 5.73e-15
|
MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 22q13.33 | 0.211 | 0.332 | 2.6e-12
|
DPP9 | dipeptidyl-peptidase 9 | 19p13.3 | 0.211 | -0.214 | 8.36e-06
|
AAMP | angio-associated, migratory cell protein | 2q | 0.21 | -0.294 | 7.18e-10
|
DLL3 | delta-like 3 (Drosophila) | 19q13.2 | 0.208 | 0.32 | 1.73e-11
|
LOC646762 | | | 0.207 | 0.217 | 6.36e-06
|
YIPF3 | Yip1 domain family, member 3 | 6p21.1 | 0.206 | -0.287 | 1.84e-09
|
GRPEL1 | GrpE-like 1, mitochondrial (E. coli) | 4p16 | 0.205 | -0.221 | 4.08e-06
|
TRIM38 | tripartite motif containing 38 | 6p21.3 | 0.204 | -0.248 | 2.19e-07
|
CCNJL | cyclin J-like | 5q33.3 | 0.204 | -0.367 | 5.19e-15
|
ADRA2B | adrenoceptor alpha 2B | 2q11.2 | 0.204 | 0.21 | 1.21e-05
|
GFAP | glial fibrillary acidic protein | 17q21 | 0.203 | 0.207 | 1.7e-05
|
WBP5 | WW domain binding protein 5 | Xq22.2 | 0.202 | -0.233 | 1.17e-06
|
ULBP1 | UL16 binding protein 1 | 6q25 | 0.2 | 0.275 | 8.22e-09
|
DLX4 | distal-less homeobox 4 | 17q21.33 | 0.2 | 0.165 | 0.000633
|
PCDHA3 | protocadherin alpha 3 | 5q31 | 0.198 | 0.161 | 0.000826
|
ING1 | inhibitor of growth family, member 1 | 13q34 | 0.197 | 0.084 | 0.0834
|
HAX1 | HCLS1 associated protein X-1 | 1q21.3 | 0.197 | 0.184 | 0.000133
|
CLCN5 | chloride channel, voltage-sensitive 5 | Xp11.23-p11.22 | 0.195 | 0.183 | 0.000153
|
THTPA | thiamine triphosphatase | 14q11.2 | 0.192 | 0.172 | 0.000366
|
TP53I3 | tumor protein p53 inducible protein 3 | 2p23.3 | 0.19 | -0.22 | 4.94e-06
|
TUSC1 | tumor suppressor candidate 1 | 9p21.2 | 0.188 | 0.251 | 1.53e-07
|
GTPBP1 | GTP binding protein 1 | 22q13.1 | 0.182 | -0.04 | 0.408
|